VR headset teaches breast cancer survivors about heart risks

NCT ID NCT07426913

Recruiting now Knowledge-focused Sponsor: Virginia Commonwealth University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 02, 2026 · Updated 2 times

Summary

This study tests a virtual reality program called SurviVRSE that teaches breast cancer survivors about heart health. Thirty women currently receiving certain cancer treatments will use the VR headset during one infusion session. Researchers will measure how much they learn, how easy the system is to use, and whether they find it helpful.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: virtual reality education program
What this could lead to: If successful, this VR program could become a tool to help breast cancer survivors learn about heart risks and adopt healthier habits.
What could go wrong: This is a small, early-phase study focused on feasibility, not on proving health outcomes. The results may not apply to all survivors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTHRACYCLINE RELATED CARDIOTOXICITY IN BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm cardiomyopathy due to anthracyclines

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANTHRACYCLINE RELATED CARDIOTOXICITY IN BREAST CANCER BREAST CANCER TRASTUZUMAB VIRTUAL REALITY

Contacts and locations

Locations

Adult Outpatient Pavilion
RECRUITING

Richmond, Virginia, 23220, United States
Cellular Immunotherapies and Transplant Department
RECRUITING

Richmond, Virginia, 23220, United States
VCU Health at Stony Point
RECRUITING

Richmond, Virginia, 23223, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.